Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2754764 | 0.83 | MMP2 (0.74) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL2603444 | 0.83 | MMP2 (0.74) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL1439573 | 0.83 | MMP2 (0.74) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL18328548 | 0.83 | MMP2 (0.74) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL15313391 | 0.83 | MMP2 (0.74) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL17715454 | 0.75 | MMP2 (0.43) | CYP19A1MMP2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL9334177 | 0.74 | MMP2 (0.55) | CYP19A1MMP2PTPN2PTPN1CYP2C9 | |
| SCHEMBL15072074 | 0.74 | MMP2 (0.49) | MMP2PTPN2PTPN1CYP2C9CYP2C19 | |
| SCHEMBL16906147 | 0.72 | MMP2 (0.40) | MMP2CYP2C9CYP2C19ALOX15ALDH1A1 | |
| SCHEMBL18949252 | 0.70 | CYP19A1 (0.60) | CYP19A1MMP2PTPN2PTPN1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025042871-A1 | ENCODING CYCLIC TERPENOIDS INTO ISOMERIC MODULAR SUBSTRATES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2025-02-27 | — | — | WO | disclosed |
| US-11566265-B2 | Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-01-31 | — | — | US | disclosed |
| US-20210395763-A1 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2021-12-23 | — | — | US | disclosed |
| EP-3833754-A2 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | Board of Trustees of Michigan State University (US) | 2021-06-16 | — | — | EP | disclosed |
| WO-2020033705-A2 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395763-A1 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | FADS2, SCD, FADS1 | CYP19A1 458/4885MMP2 3568/4885PTPN2 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.